Similar Papers

Paper Title
Journal
Date
Author
Organ Biomarker Responses in Patients with Light Chain Amyloidosis Treated with NEOD001 Are Independent of Previous Hematologic Response
Michaela Liedtke ... Morie A Gertz
Blood | VOL. 128
Michaela Liedtke, et. al.Michaela Liedtke ... Morie A Gertz
02 Dec 2016
NEOD001 Demonstrates Organ Biomarker Responses in Patients with Light Chain Amyloidosis and Persistent Organ Dysfunction: Results from the Expansion Cohort of a Phase 1/2 Study
Morie A Gertz ... Michaela Liedtke
Blood | VOL. 128
Morie A Gertz, et. al.Morie A Gertz ... Michaela Liedtke
02 Dec 2016
The VITAL Amyloidosis Study: A Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study of NEOD001 in Patients with AL Amyloidosis and Cardiac Dysfunction
Michaela Liedtke ... Morie A Gertz
Blood | VOL. 128
Michaela Liedtke, et. al.Michaela Liedtke ... Morie A Gertz
02 Dec 2016
Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study
...
Blood | VOL. 138
, et. al. ...
05 Nov 2021
View more papers

More From: Clinical Lymphoma Myeloma and Leukemia

Paper Title
Journal
Date
Author
Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis
Moazzam Shahzad ... Muhammad Umair Mushtaq
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Moazzam Shahzad, et. al.Moazzam Shahzad ... Muhammad Umair Mushtaq
01 Jan 2025
Effect of TKI maintenance therapy after allogeneic hematopoietic stem cell transplantation on recurrence of Philadelphia chromosome-positive acute lymphoblastic leukemia p190 and p210 transcripts - a multicentre study
Jiayi Zhen ... Ganlin He
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Jiayi Zhen, et. al.Jiayi Zhen ... Ganlin He
01 Jan 2025
Disease characteristics and treatment outcomes of Myeloma patients under 50 years of age: an analysis of the Balkan Myeloma Study Group
Despina Fotiou ... Efstathios Kastritis
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Despina Fotiou, et. al.Despina Fotiou ... Efstathios Kastritis
01 Jan 2025
Inotuzumab Ozogamicin as First-Line Therapy in Acute Lymphoblastic Leukemia
Elias J Jabbour ... Matthias Stelljes
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Elias J Jabbour, et. al.Elias J Jabbour ... Matthias Stelljes
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.